Dr Sarah Byron is the Programme Director for HealthTech Strategy and Development at NICE.

In this role, she works collaboratively with partners across the NHS and wider life science ecosystem to shape the HealthTech strategy at NICE and lead development projects that solve key challenges, both internally and externally. Most recently, Sarah led the development of the new Early Value Assessment approach for health technologies that address key NHS needs, helping to build the evidence base for widespread adoption through early deployment in the NHS.

Previously, Sarah was responsible for the NICE guidance programme evaluating the value of devices, diagnostics and digital technologies to improve patient access and care, and address NHS system challenges. Prior to NICE, she completed a PhD in Biochemistry and worked in the pharmaceutical industry.